GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » LT-Debt-to-Total-Asset

PANC (Panacos Pharmaceuticals) LT-Debt-to-Total-Asset : 0.38 (As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Panacos Pharmaceuticals's long-term debt to total assests ratio for the quarter that ended in Sep. 2008 was 0.38.

Panacos Pharmaceuticals's long-term debt to total assets ratio increased from Sep. 2007 (0.17) to Sep. 2008 (0.38). It may suggest that Panacos Pharmaceuticals is progressively becoming more dependent on debt to grow their business.


Panacos Pharmaceuticals LT-Debt-to-Total-Asset Historical Data

The historical data trend for Panacos Pharmaceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals LT-Debt-to-Total-Asset Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.01 - - 0.30

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.30 0.31 0.33 0.38

Panacos Pharmaceuticals LT-Debt-to-Total-Asset Calculation

Panacos Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2007 is calculated as

LT Debt to Total Assets (A: Dec. 2007 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2007 )/Total Assets (A: Dec. 2007 )
=16.535/55.71
=0.30

Panacos Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2008 is calculated as

LT Debt to Total Assets (Q: Sep. 2008 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2008 )/Total Assets (Q: Sep. 2008 )
=11.152/29.738
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacos Pharmaceuticals  (GREY:PANC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Panacos Pharmaceuticals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals Headlines

No Headlines